← Leaderboards
Mary Cm Weiser-Evans
University Of Colorado Denver
$14,403,734
Attributed
$17,020,526
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,020,526 · 10
By mechanism
R01$13,982,575 · 5
P01$1,645,038 · 1
R21$1,217,461 · 3
T32$175,452 · 1
Top collaborators
- Mark W. Majesky7 shared
- Raphael A. Nemenoff2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kurt R Stenmark$22,132,904
- Makoto Miyazaki$12,138,675
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsIn VitroCellsMolecularSmooth Muscle MyocytesTranscription FactorPhenotypeInjuryPathway InteractionsResponseAtherosclerosisVascular RemodelingStem CellsSignal TransductionInflammatoryExhibitsIn VivoPten GeneMediatingPlayGrowthRegulationMouse ModelIn Situ
Grant awards (39)
Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis$758,147
R01 · FY2025 · HL · contact PI
Predoctoral Training in the Physiology of Human Health and Disease (PHHD)$175,452
T32 · FY2025 · GM · contact PI
Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis$742,984
R01 · FY2024 · HL · contact PI
PTEN promoter hypermethylation underlies vascular disease progression$562,216
R01 · FY2024 · HL · contact PI
Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis$772,147
R01 · FY2023 · HL · contact PI
PTEN promoter hypermethylation underlies vascular disease progression$573,689
R01 · FY2023 · HL · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$637,559
R01 · FY2022 · HL · contact PI
PTEN promoter hypermethylation underlies vascular disease progression$573,689
R01 · FY2022 · HL · contact PI
The Lung Tumor Microenvironment: Role of Resident Pulmonary Vascular Progenitor Cells in Cancer Progression and Metastasis$178,107
R21 · FY2022 · CA · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$637,559
R01 · FY2021 · HL · contact PI
PTEN promoter hypermethylation underlies vascular disease progression$573,689
R01 · FY2021 · HL · contact PI
The Lung Tumor Microenvironment: Role of Resident Pulmonary Vascular Progenitor Cells in Cancer Progression and Metastasis$218,089
R21 · FY2021 · CA · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$637,559
R01 · FY2020 · HL · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$651,434
R01 · FY2019 · HL · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$546,058
R01 · FY2018 · HL · contact PI
PTEN-dependent regulation of SRF transcriptional activity and SMC phenotype control$495,537
R01 · FY2018 · HL · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$546,463
R01 · FY2017 · HL · contact PI
PTEN-dependent regulation of SRF transcriptional activity and SMC phenotype control$495,537
R01 · FY2017 · HL · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$546,859
R01 · FY2016 · HL · contact PI
PTEN-dependent regulation of SRF transcriptional activity and SMC phenotype control$495,537
R01 · FY2016 · HL · contact PI
Reprogramming of mature smooth muscle cells to vascular progenitor cells$560,137
R01 · FY2015 · HL · contact PI
PTEN-dependent regulation of SRF transcriptional activity and SMC phenotype control$495,271
R01 · FY2015 · HL · contact PI
Microenvironmental Endogenous Reprogramming of Differentiated Smooth Muscle Cells$189,722
R21 · FY2014 · HL · contact PI
Role of PTEN in Hypoxia-Induced Vascular Remodeling, Raphael Nemenoff$313,522
P01 · FY2013 · HL · contact PI
Microenvironmental Endogenous Reprogramming of Differentiated Smooth Muscle Cells$220,567
R21 · FY2013 · HL · contact PI
Role of PTEN in Vascular Lesion Formation$368,181
R01 · FY2012 · HL · contact PI
Role of PTEN in Hypoxia-Induced Vascular Remodeling, Raphael Nemenoff$361,872
P01 · FY2012 · HL · contact PI
Role of PTEN in Vascular Lesion Formation$371,900
R01 · FY2011 · HL · contact PI
Role of PTEN in Hypoxia-Induced Vascular Remodeling, Raphael Nemenoff$327,820
P01 · FY2011 · HL · contact PI
Role of PTEN in Vascular Lesion Formation$372,571
R01 · FY2010 · HL · contact PI
Role of PTEN in Hypoxia-Induced Vascular Remodeling, Raphael Nemenoff$320,389
P01 · FY2010 · HL · contact PI
Role of PTEN in Vascular Lesion Formation$373,721
R01 · FY2009 · HL · contact PI
Role of PTEN in Hypoxia-Induced Vascular Remodeling, Raphael Nemenoff$321,435
P01 · FY2009 · HL · contact PI
PTEN and Perlecan in Reducing In-Stent Restenosis$184,296
R21 · FY2007 · EB · contact PI
PTEN and Perlecan in Reducing In-Stent Restenosis$226,680
R21 · FY2006 · EB · contact PI
EMBRYONIC GENES IN SMC GROWTH AFTER VASCULAR INJURY$298,377
R01 · FY2003 · HL
EMBRYONIC GENES IN SMC GROWTH AFTER VASCULAR INJURY$298,483
R01 · FY2002 · HL
EMBRYONIC GENES IN SMC GROWTH AFTER VASCULAR INJURY$298,586
R01 · FY2001 · HL
EMBRYONIC GENES IN SMC GROWTH AFTER VASCULAR INJURY$298,685
R01 · FY2000 · HL